← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2000Last known activity
Oct 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 9 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT02862236CollaboratorPhase 4Oct 1, 2016
- NCT02862236Overall official - principal investigatorPhase 4Oct 1, 2016
- NCT02907437Lead sponsorPhase 3Jan 1, 2015
- NCT02907437Reponsible party - principal investigatorPhase 3Jan 1, 2015
- NCT02907437Overall official - principal investigatorPhase 3Jan 1, 2015
- NCT01689740Overall official - principal investigatorPhase 2Oct 1, 2013
- NCT00845936Lead sponsorPhase 4May 1, 2009
- NCT00708396Lead sponsorPhase 4Jul 1, 2008
- NCT00465283Lead sponsorPhase 4May 1, 2007
- NCT00465283Overall official - principal investigatorPhase 4May 1, 2007
- NCT00456937Overall official - principal investigatorPhase 4Jul 1, 2006
- NCT00456937Lead sponsorPhase 4Jul 1, 2006
- NCT00148447Study chairPhase 3Nov 1, 2004
- NCT00148447Overall official - principal investigatorPhase 3Nov 1, 2004
- NCT00148447Lead sponsorPhase 3Nov 1, 2004
Details
- Last known activity
- Oct 1, 2016